Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature.
D000367:Age Factors; D000368:Aged; D000380:Agranulocytosis / Q000209:etiology; D000469:Alkaline Phosphatase / Q000032:analysis; D000728:Androgens / Q000627:therapeutic use; D000756:Anemia, Sideroblastic / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D001803:Blood Transfusion; D001856:Bone Marrow Examination; D004920:Erythropoiesis; D005260:Female; D006333:Heart Failure / Q000150:complications; D006418:Heme / Q000096:biosynthesis; D006432:Hemochromatosis / Q000209:etiology; D006529:Hepatomegaly / Q000209:etiology; D006801:Humans; D007501:Iron / Q000378:metabolism; D007855:Lead Poisoning / Q000150:complications; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D007962:Leukocytes / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009748:Nutrition Disorders / Q000150:complications; D011166:Porphyrins / Q000378:metabolism; D011485:Protein Binding; D012737:Sex Factors; D013163:Splenomegaly / Q000209:etiology; D013921:Thrombocytopenia / Q000209:etiology
D000728:Androgens; D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D011166:Porphyrins; D006418:Heme; D007501:Iron; D000469:Alkaline Phosphatase